Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market. It also offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. The company was incorporated in 2021 and is based in Tampa, Florida.
IPO Year: 2021
Exchange: NASDAQ
Website: marpaihealth.com
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
10-Q - Marpai, Inc. (0001844392) (Filer)
8-K - Marpai, Inc. (0001844392) (Filer)
10-K - Marpai, Inc. (0001844392) (Filer)
8-K - Marpai, Inc. (0001844392) (Filer)
SCHEDULE 13G/A - Marpai, Inc. (0001844392) (Subject)
8-K - Marpai, Inc. (0001844392) (Filer)
8-K - Marpai, Inc. (0001844392) (Filer)
SCHEDULE 13G/A - Marpai, Inc. (0001844392) (Subject)
8-K - Marpai, Inc. (0001844392) (Filer)
10-Q - Marpai, Inc. (0001844392) (Filer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
4 - Marpai, Inc. (0001844392) (Issuer)
Fastest customizable press release news feed in the world
TAMPA, Fla., May 26, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit Management ("PBM") services, today announced a historic expansion of its business book. Following a series of newly secured commitments and confirmed new business across its Third-Party Administrator (TPA) and MarpaiRx Pharmacy Benefit Management (PBM) platforms, the Company estimates a total increase of 192,000 member lives scheduled to roll out between August 2026 and January 2027.This influx represents a nearly six-fold increase in the Company's current member lives, potentially transforming
Strategic Investments in Operations and Technology Fuel Platform for Accelerated Growth and Aim of Second-Half 2026 ProfitabilityTAMPA, Fla., May 15, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management ("PBM") services, announced the financial results for the first quarter 2026.Marpai's first quarter 2026 results reflect the Company's continued execution of its operational transformation designed to position the business for profitability and growth. The Company has nearly completed the migration of its IT and claims processing to a single, unified cloud-bas
TAMPA, Fla., May 11, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit Management ("PBM") services, today announced several significant new business wins across its core TPA and MarpaiRx divisions. These new client wins, representing a diverse range of self-insured employer groups, are expected to be primary drivers in the Company's path toward achieving sustained profitability.Pursuant to the newly secured contracts, Marpai is expected to provide comprehensive TPA services and integrated pharmacy benefit management services through MarpaiRx, reflect the growing de
TAMPA, Fla., April 1, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, today announced the execution of what the Company believes is its largest to date definitive marketing agreement with a leading healthcare solutions provider. This strategic collaboration is designed to scale the reach of MarpaiRx, Marpai's pharmacy benefit management (PBM) services, across a vast network of self-insured employer groups and third-party administrators.Under the terms of the three-year agreement, the team will leverage its extensive domestic and internati
Marketing Agreement Establishes Powerful National Distribution Channel and Expands Marpai's Revenue Growth OpportunityTAMPA, Fla., March 9, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, today announced the execution of a transformational marketing agreement dramatically expanding the national reach of its high-growth pharmacy benefit management division, providing access to a network representing up to 1.5 million covered employees for MarpaiRx.The agreement creates a powerful new distribution channel for MarpaiRx's pharmacy benefit sol
New Client Momentum Highlights Rapid Adoption of Marpai's Disruptive, Scalable Healthcare Platform Positioned to Drive Exponential Revenue Growth and Long-Term Shareholder ValueTAMPA, Fla., Feb. 23, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, today announced two significant strategic client wins for its high-growth MarpaiRx division, adding more than 19,000 covered lives and further accelerating the Company's expansion as a next-generation healthcare platform.We believe that these wins represent strong validation of Marpai's different
TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With
Renews Aetna Signature Administrator Network Agreement and Enhances Cost Containment with Faircost Optimizer TAMPA, Fla., Dec. 1, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced significant positive momentum heading into the new year, highlighted by a better-than-expected sales cycle for 2026 and the renewal of its critical network access agreement with Aetna. The Company reports a robust sales cycle, securing a volume of new clients for January 1, 2026, that surpasses internal expectations, reinforcing its path to scalable growt
Continued Turnaround Driven by Cost Discipline and Operational Efficiency; Positioned for Strong 2026 Growth TAMPA, Fla., Nov. 12, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, announced third quarter 2025 results that mark another quarter of significant operational and financial improvement, underscoring the success of its transformation strategy and the Company's emergence as a disciplined, scalable growth platform heading into 2026. For the third quarter ended September 30, 2025, Marpai continued its turnaround trajectory, achieving meaningful advances in cost control,
TAMPA, Fla., Nov. 6, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services. The Company will host a conference call and webcast on Thursday, November 13 at 8:30 a.m. ET to present the Company's operational and financial highlights for Q3 2025. The Company will report its third quarter 2025 results on Wednesday after the market close. Event: Marpai 2025 Q3 Financial Results Conference Call Date: November 13, 2025 Time: 8:30 a.m. Eastern Time Call: US: 1-646-357-8785 / Toll Free: 1-800-836-8184 Webcast: https://app.webinar.net/934VMynbB6a Follow us on X.com and LinkedIn You may str
Live finance-specific insights
Continued Turnaround Driven by Cost Discipline and Operational Efficiency; Positioned for Strong 2026 Growth TAMPA, Fla., Nov. 12, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, announced third quarter 2025 results that mark another quarter of significant operational and financial improvement, underscoring the success of its transformation strategy and the Company's emergence as a disciplined, scalable growth platform heading into 2026. For the third quarter ended September 30, 2025, Marpai continued its turnaround trajectory, achieving meaningful advances in cost control,
TAMPA, Fla., Nov. 6, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services. The Company will host a conference call and webcast on Thursday, November 13 at 8:30 a.m. ET to present the Company's operational and financial highlights for Q3 2025. The Company will report its third quarter 2025 results on Wednesday after the market close. Event: Marpai 2025 Q3 Financial Results Conference Call Date: November 13, 2025 Time: 8:30 a.m. Eastern Time Call: US: 1-646-357-8785 / Toll Free: 1-800-836-8184 Webcast: https://app.webinar.net/934VMynbB6a Follow us on X.com and LinkedIn You may str
Marpai Slashes Losses by Two-Thirds in Q2 2025, Paving the Way to Profitability.Operating Expenses Cut 70% as Turnaround Gains Traction TAMPA, Fla., Aug. 13, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, today announced second quarter 2025 results that mark a decisive step forward in its turnaround strategy. The Company delivered substantial quarterly year-over-year improvements across key financial metrics: Operating expenses down 70%, saving $9.9 millionOperating loss reduced by 71% to $3.6 million, an $8.7 million improvementNet loss reduced by 66% to $4.4 million, als
TAMPA, Fla., Aug. 7, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services. The Company will host a conference call and webcast on Thursday, August 14 at 8:30 a.m. ET to present the Company's operational and financial highlights for Q2 2025. The Company will report its second quarter 2025 results on Wednesday after the market close. Event: Marpai 2025 Q2 Financial Results Conference Call Date: August 14, 2025 Time: 8:30 a.m. Eastern Time Call: US: 1-646-357-8785 / Toll Free: 1-800-836-8184 Webcast: https://app.webinar.net/pD32GbLd5Mx Follow us on X.com and LinkedIn You may strea
Marpai's turnaround momentum is building TAMPA, Fla., May 14, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, announced financial results for the first quarter of 2025. The Company expects to hold a webcast to discuss the results on May 15, 2025. Marpai CEO Damien Lamendola commented, "Our consistent double-digit success in cutting operating expenses and improving our bottom line signals what we believe is a critical inflection point for the Company. Looking ahead to the second quarter, we are focused on completing several key initiatives, including the launch of our Health
TAMPA, Fla., May 7, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services. The Company will host a conference call and webcast on Thursday, May 15 at 8:30 a.m. ET to present the Company's operational and financial highlights for Q1 2025. The Company will report its first quarter 2025 results on Wednesday after the market close. Event: Marpai 2025 Q1 Financial Results Conference Call Date: May 15, 2025 Time: 8:30 a.m. Eastern Time Call: US: 1-646-357-8785 / Toll Free: 1-800-836-8184 Webcast: https://app.webinar.net/e6RGaxOgz3n Follow us on X.com and LinkedIn You may stream th
TAMPA, Fla., March 20, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a technology platform company, operates as a national Third-Party Administrator (TPA) through its subsidiaries. We're transforming the $22 billion TPA market by offering affordable, intelligent, healthcare solutions to self-funded employer health plans. The Company will host a conference call and webcast on Thursday, March 27 at 8:30 a.m. ET to present the Company's operational and financial highlights for 2024. The Company will report its fourth quarter and full year 2024 results on Wednesday after the market close. Event: Marpai 2024 Financial Results Conference Call Date: March 27, 2025 Time
TAMPA, Fla., Nov. 8, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a technology platform company, operates as a national Third-Party Administrator (TPA) through its subsidiaries. We're transforming the $22 billion TPA market by offering affordable, intelligent, healthcare solutions to self-funded employer health plans. The Company will host a conference call and webcast on Tuesday, November 12 at 8:30 a.m. ET to present the Company's operational and financial highlights for its third quarter 2024. The Company will report its third quarter results on Monday after the market close. Event: Marpai Third Quarter Financial Results Conference Call Date: November 12, 20
TAMPA, Fla., Aug. 2, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology platform company, operates as a national Third-Party Administrator (TPA) through its subsidiaries. We're transforming the $22 billion TPA market by offering affordable, intelligent, healthcare solutions to self-funded employer health plans. The Company will host a conference call and webcast on Thursday, August 8 at 8:30 a.m. ET to answer questions about the Company's operational and financial highlights for its second quarter 2024. The Company will report its second quarter results on Wednesday after the market close. Event: Marpai Second Quarter Financial Results Conference Call D
TAMPA, Fla., May 3, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (NASDAQ:MRAI), an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, will host a conference call and webcast on Friday, May 10 at 8:30 a.m. ET to answer questions about the Company's operational and financial highlights for its first quarter 2024. The Company will report its first quarter results on Thursday after the market close. Event: Marpai First Quarter Financial Results Conference Call Date: May 10, 2024 Time: 8:30 a.m. Eastern Time Live Call: US: 1-646-357-8785 / T
Live Leadership Updates
Strategic Investments in Operations and Technology Fuel Platform for Accelerated Growth and Aim of Second-Half 2026 ProfitabilityTAMPA, Fla., May 15, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management ("PBM") services, announced the financial results for the first quarter 2026.Marpai's first quarter 2026 results reflect the Company's continued execution of its operational transformation designed to position the business for profitability and growth. The Company has nearly completed the migration of its IT and claims processing to a single, unified cloud-bas
TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With
Marpai Bolsters Leadership Team to Drive Profitable High-Growth Strategy with Key Executive Appointment TAMPA, Fla., May 13, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, today announced a significant addition to its leadership team with the appointment of Dallas Scrip as Chief Operating Officer (COO) and President of MarpaiRx. This strategic hire underscores Marpai's commitment to accelerating profitable growth and enhancing operational excellence within the dynamic healthcare landscape. Prior to joining Marpai, Mr. Scrip demonstrated significant success in startup, ear
STUART, Fla., Jan. 22, 2025 /PRNewswire/ -- Health In Tech, an Insurtech platform company backed by third-party AI technology, is thrilled to announce a new strategic collaboration with Vitable and MARPAI. This collaboration aims to introduce a competitively priced self-funded health plan to the market. By utilizing the strength of Vitable's Direct Primary Care (DPC), a health plan, and stop-loss coverage, Health In Tech seeks to offer low quotes on their eDIYBS platform, and to set an ambitious standard in affordability and efficiency. Vitable's enhanced primary care plan co
Highlights Urgent Need for An Independent Director Perspective to Address Genco's Persistent Underperformance and Unlock Value for Shareholders Outlines Concerns with Chairman James Dolphin's Outsized Influence in the Genco Boardroom Urges Shareholders to Vote FOR the Election of GK Investor Nominee Robert Pons on the BLUE Universal Proxy Card and WITHHOLD on Genco Board Chairman James Dolphin GK Investor LLC ("GK"), an affiliate of George Economou that is an approximately 5.3% shareholder of Genco Shipping & Trading Limited ("Genco" or the "Company") (NYSE:GNK), today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connec
Accomplished Industry Veteran with Proven Track Record of Successful High Growth Operations to support Marpai's vision of Affordable, Intelligent, Healthcare NEW YORK, Jan. 12, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (NASDAQ:MRAI), an independent national Third-Party Administration company transforming the $22 billion TPA market supporting self-funded employer health plans, today announced the appointment of John Powers as the Company's President. Powers is an accomplished healthcare benefits executive with over 30 years' experience. Powers was previously CEO of Homestead Smart Health Plans. Powers brings deep operations knowledge and an extensive industry network devel
NEW YORK, Dec. 13, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (NASDAQ:MRAI), an independent national Third-Party Administrator (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans, today announced the addition of two new members to its Board of Directors (the "Board") as part of the Company's ongoing transformation plan and commitment to strong corporate governance and shareholder value creation. Effective December 7, 2023, Jennifer Calabrese and Robert Pons joined Marpai's Board as new independent directors. In addition, the Board will also implement a strategic plan designed to enhance the Company's performance and drive shar
This live feed shows all institutional transactions in real time.
SC 13D/A - Marpai, Inc. (0001844392) (Subject)
SC 13D/A - Marpai, Inc. (0001844392) (Subject)
SC 13D/A - Marpai, Inc. (0001844392) (Subject)
SC 13D/A - Marpai, Inc. (0001844392) (Subject)
SC 13D/A - Marpai, Inc. (0001844392) (Subject)
SC 13D/A - Marpai, Inc. (0001844392) (Subject)
SC 13D/A - Marpai, Inc. (0001844392) (Subject)
SC 13D/A - Marpai, Inc. (0001844392) (Subject)
SC 13D/A - Marpai, Inc. (0001844392) (Subject)
SC 13D/A - Marpai, Inc. (0001844392) (Subject)